Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Infographics
Dermatology
12 Sep 2025
The POSITIVE Phase IV Study: Interim 52-Week Results on Patient Well-Being With Tildrakizumab
Psoriatic disease extends beyond the skin, imposing a significant psychosocial burden, often leading to embarrassment, social withdrawal…
Hematology
3 Sep 2025
Update to European Treatment Guideline for Large B Cell Lymphomas
Neurology
31 Jul 2025
CANYON: The Largest Interventional Trial in Becker
Sevasemten is an investigational agent that is currently not approved for use by any regulatory authority in any territory…
Hematology
24 Jul 2025
Ranking Treatments for Lenalidomide-Refractory Multiple Myeloma post DRd
Multiple myeloma is the second most common haematological malignancy, with an increasing global incidence…
Hematology
24 Jul 2025
The Immunotherapy Landscape for Multiple Myeloma
Take a look at our latest haematology infographic, which explores the current immunotherapy treatment landscape for multiple myeloma…
Neurology
16 Jul 2025
Unseen burden of CIDP
A discussion with a COPD specialist to elucidate the importance of selecting the right inhalation device for each patient using the…
Interventional Cardiology
3 Jul 2025
Role of Intravascular Imaging in Optimising PCI Outcomes
Techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are increasingly recommended to guide PCI in complex…
Neurology
30 Jun 2025
Evolution of gMG Therapy
This infographic explores gMG pathophysiology, key symptoms and emerging treatment options
Loading posts...
1
2
3
…
17
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View